Norma November

Sepsim is a breakthrough biotech company developing a novel drug to combat Sepsis and MRSA—two of the deadliest threats in modern medicine. In preclinical animal trials, the results were nothing short of extraordinary: 100% survival in treated subjects, compared to 100% mortality in untreated controls. Our mission is clear and urgent: to solve Sepsis, a condition that claims millions of lives each year with limited effective treatments available. At Sepsim, we believe the cure starts here.

BrilliSkin is revolutionizing access to dermatologic care with a fast, affordable, and inclusive teledermatology platform. Users can simply snap a photo of their skin concern and connect with a board-certified dermatologist within 24 hours for about 10% of the cost of a traditional visit. With multilingual support and a focus on underserved communities, BrilliSkin breaks down the barriers of geography, cost, and language to make expert skincare accessible to everyone. Were on a mission to make skin health a right, not a privilege.

Single urine test for multiple cancer detection

Vistim Labs mission is to enable clinicians to offer instant, in-clinic brain monitoring with similar insights as PET, CSF, and cognitive testing, for monitoring neurodegenerative disease progression. Our mission is give doctors the means to cure devastating diseases like Alzheimers, by providing a feedback loop to know when treatments are working. We are valued for our ability to correlate across all relevant biomarkers in a single EEG. Research shows that our technology is capable of generating full-resolution PET imaging with exceptional concordance. Very high correlation with endpoints like: cognitive performance, amyloid & tau accumulation, alpha-synuclein, and neurodegeneration. As far as we know, we are the only EEG technology in the world with research demonstrating structural brain-imaging capabilities.

SeeMedX is revolutionizing the noninvasive heart monitoring space with its patented technology that can save lives and improve patient outcomes. The team has a proven track record of success in both the medical and business industries, with experience in bringing products to market and scaling businesses.

RainIons technology cleans the air via a unique combination of negative ions and precipitation. This new technology breakthrough replicates the way Mother Nature cleans the air, but instead of transferring the pollution from the air to the ground and water, the pollution will be captured inside the system so it can be completely eliminated from the environment. A feasibility study determined the patented innovation could reduce airborne pollutants by 99%, including Particulate Matter (PM) 2.5 and smaller, and CO2.

ENDOSURE, INC. was founded based on a new approach to empower physicians with the tools they need for earlier, more accurate endometriosis diagnosis. To that end, we proudly offer the ENDOSURE TEST, the first and only Tier-1 diagnostic test for endometriosis. Since its introduction in 2022, this groundbreaking clinical support tool has already begun to shift the entire paradigm in how medical providers detect and treat endometriosis. The ENDOSURE TEST meets all major requirements of a Tier-1 diagnostic test, offering critical advantages: 🔹️ Low cost 🔹️ Easy-to-use 🔹️ Non-invasive 🔹️ Rapid results (30 minutes) 🔹️ Highly accurate (surgically verified) 🔹️ No population-related use restriction (detects disease in patients of any age, at any stage, anywhere in the anatomy) The ENDOSURE TEST is actively being used in many gynecology practices around the world, equipping medical providers with the means to detect endometriosis at its earliest stages and offer targeted, personalized therapy to their patients. At ENDOSURE, INC., we are committed to a future in endometriosis care where timely diagnosis is no longer a barrier to effective disease management, and no woman must wait nearly a decade for a definitive diagnosis.

Sepsim is a breakthrough biotech company developing a novel drug to combat Sepsis and MRSA—two of the deadliest threats in modern medicine. In preclinical animal trials, the results were nothing short of extraordinary: 100% survival in treated subjects, compared to 100% mortality in untreated controls. Our mission is clear and urgent: to solve Sepsis, a condition that claims millions of lives each year with limited effective treatments available. At Sepsim, we believe the cure starts here.